# Christopher Green

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-green/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,454 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 61 |
| i10-index | 153 |
| Last Known Institution | University Hospitals Birmingham NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5100783055 |
| ORCID iD | https://orcid.org/0000-0002-1984-4014 |
| Works | 318 |

## Researcher papers

- [Dexamethasone in Hospitalized Patients with Covid-19.](https://scholariq.org/papers/dexamethasone-in-hospitalized-patients-with-covid-19/)
- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report](https://scholariq.org/papers/effect-of-dexamethasone-in-hospitalized-patients-with-covid-19-preliminary/)
- [Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/lopinavir-ritonavir-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19](https://scholariq.org/papers/effect-of-noninvasive-respiratory-strategies-on-intubation-or-mortality-among/)
- [Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19](https://scholariq.org/papers/inflammatory-profiles-across-the-spectrum-of-disease-reveal-a-distinct-role-for/)
- [Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study](https://scholariq.org/papers/development-and-validation-of-the-isaric-4c-deterioration-model-for-adults/)
- [SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination](https://scholariq.org/papers/sars-cov-2-specific-nasal-iga-wanes-9-months-after-hospitalisation-with-covid-19/)
- [Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK](https://scholariq.org/papers/changes-in-in-hospital-mortality-in-the-first-wave-of-covid-19-a-multicentre/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Respiratory viral infections research](https://scholariq.org/topics/respiratory-viral-infections-research/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)

## Researcher university

- [University Hospitals Birmingham NHS Foundation Trust](https://scholariq.org/institutions/university-hospitals-birmingham-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.